Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002988719 | SCV003291895 | uncertain significance | not provided | 2023-08-22 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 2078600). This variant is present in population databases (rs778469245, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 2959 of the HMCN1 protein (p.Asn2959Ser). |
Ambry Genetics | RCV004065198 | SCV003651059 | uncertain significance | not specified | 2022-03-29 | criteria provided, single submitter | clinical testing | The c.8876A>G (p.N2959S) alteration is located in exon 57 (coding exon 57) of the HMCN1 gene. This alteration results from a A to G substitution at nucleotide position 8876, causing the asparagine (N) at amino acid position 2959 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003455647 | SCV004179848 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |